KURA BIOTEC SPA – Trademark Portfolio
Entity Type: 99
KURA BIOTEC SPA holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include B-ONE, BG100, BLIKKA, AVENIRE, and BGTURBO. The owner is based in LOS LAGOS.
AVDA.GRAMADO (INTERIOR), S/N, PARCELA
2 PUERTO VARAS
LOS LAGOS 5550168 , CL
Showing of trademarks Trademarks
Trademark Classifications
KURA BIOTEC SPA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does KURA BIOTEC SPA have?
KURA BIOTEC SPA has 10 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 abandoned, 1 cancelled.
What trademark classes does KURA BIOTEC SPA file in?
KURA BIOTEC SPA files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are KURA BIOTEC SPA's most well-known trademarks?
KURA BIOTEC SPA's registered trademark portfolio includes well-known marks such as B-ONE, BG100, BLIKKA, AVENIRE, and BGTURBO. These are among 7 currently registered trademarks in the portfolio.
What is KURA BIOTEC SPA's trademark registration success rate?
KURA BIOTEC SPA has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.